NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.

CONCLUSIONS: The present study characterizes metabolic disturbances in both tissue and biofluid samples during PCa progression and provides potential diagnostic biomarkers and therapeutic targets for PCa.
PMID: 31758937 [PubMed - as supplied by publisher]

Source: International Journal of Clinical Chemistry - November 19, 2019 Category: Chemistry Authors: Zheng H, Dong B, Ning J, Shao X, Zhao L, Jiang Q, Ji H, Cai A, Xue W, Gao H Tags: Clin Chim Acta Source Type: research